Solésence receives Nasdaq bid-price deficiency notice; has until March 29, 2027 to regain $1.00 compliance

SOLESENCE, INC.

Nasdaq Listing Qualifications notice dated September 29, 2026: SLSN closing bid price fell below $1.00 per share for 30 consecutive trading days, breaching Listing Rule 5550(a)(2).
Company has a 180-calendar-day initial compliance period ending March 29, 2027; cure requires a closing bid of at least $1.00 for a minimum of 10 consecutive trading days.
If not cured by March 29, 2027, Solésence may qualify for an additional 180 days by meeting the market value of publicly held shares and all other Capital Market initial-listing standards.
Company says it is evaluating various courses of action; warns that non-compliance or delisting would materially and adversely affect its ability to raise capital and its financial condition.
Notice has no immediate effect on the listing of the common stock on Nasdaq Capital Market; CFO Laura Riffner signed the report dated October 2, 2026.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.